Loading...
CRLX101 (formerly IT-101)–A Novel Nanopharmaceutical of Camptothecin in Clinical Development
CRLX101 (formerly IT-101) is a first-in-class nanopharmaceutical, currently in Phase 2a development, which has been developed by covalently conjugating camptothecin (CPT) to a linear, cyclodextrin-polyethylene glycol (CD-PEG) co-polymer that self-assembles into nanoparticles. As a nanometer-scale dr...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Bentham Science Publishers Ltd
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3182091/ https://ncbi.nlm.nih.gov/pubmed/22081768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/157340711795163866 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|